Clinical Trial: Bronchiectasis Phenotype Identification Model

U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07599969) titled 'Bronchiectasis Phenotype Identification Model' on May 15.

Brief Summary: The Bronchiectasis Phenotype Identification Model (BPIM) is a prospective observational development-validation study within the Assiut University bronchiectasis translational research platform.

The study evaluates whether latent class trajectory analysis (LCTA)-derived bronchiectasis phenotype classes can be translated into a supervised baseline classifier for adults with non-cystic fibrosis bronchiectasis (NCFB).

Latent class trajectory analysis (LCTA) will first identify trajectory-derived phenotype classes using prospectively collected longitudinal disease-...